Codi QR

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter

Aim. To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibril­lation and flutter (AF/AFL).Material and methods. Fifty five patients (mean age, 65±11 years) with paroxysmal AF/AFL were included. All patients underwent a...

Descripció completa

Guardat en:
Autors principals: D. A. Gagloeva, Kh. M. Dzaurova, M. A. Zelberg, N. Yu. Mironov, Yu. A. Yuricheva, S. F. Sokolov, M. A. Krymukova, A. I. Salpagarova, L. O. Dulaev, D. V. Pevzner, S. P. Golitsyn
Format: Artigo
Idioma:Russo
Publicat: «SILICEA-POLIGRAF» LLC 2023-05-01
Col·lecció:Кардиоваскулярная терапия и профилактика
Matèries:
atrial fibrillation
paroxysmal type
refralon
amiodarone
chemical cardioversion
class iii antiarrhythmic drugs
Accés en línia:https://cardiovascular.elpub.ru/jour/article/view/3527
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars